Bergstrom (IMAGE)
Caption
This image shows first author Erik Bergstrom showcasing a biopsy analysis completed with DeepHRD, a new artificial intelligence tool that can detect clinically actionable genomic alterations directly from biopsy slides, making it significantly easier and cheaper to determine the best course of treatment for breast and ovarian cancers. The AI-analyzed image (right side on the computer screen), the areas colored in red have been identified as HRD-positive.
Credit
UC San Diego Jacobs School of Engineering
Usage Restrictions
use photo credit
License
Original content